U.S. markets open in 6 hours 5 minutes

Adient plc (ADNT)

NYSE - NYSE Delayed Price. Currency in USD
Add to watchlist
37.08+0.10 (+0.27%)
At close: 4:00PM EST
Full screen
Trade prices are not sourced from all markets
Gain actionable insight from technical analysis on financial instruments, to help optimize your trading strategies
Chart Events
Bearishpattern detected
MACD

MACD

Previous Close36.98
Open36.98
Bid0.00 x 800
Ask0.00 x 800
Day's Range35.60 - 37.70
52 Week Range5.90 - 40.45
Volume729,701
Avg. Volume891,601
Market Cap3.492B
Beta (5Y Monthly)3.34
PE Ratio (TTM)N/A
EPS (TTM)-2.45
Earnings DateApr 19, 2021 - Apr 23, 2021
Forward Dividend & YieldN/A (N/A)
Ex-Dividend DateOct 23, 2018
1y Target Est43.67
Fair Value is the appropriate price for the shares of a company, based on its earnings and growth rate also interpreted as when P/E Ratio = Growth Rate. Estimated return represents the projected annual return you might expect after purchasing shares in the company and holding them over the default time horizon of 5 years, based on the EPS growth rate that we have projected.
Fair Value
XX.XX
Overvalued
Research that delivers an independent perspective, consistent methodology and actionable insight
Related Research
View more
  • Adient will participate at the Wolfe Research Virtual Autos Conference
    PR Newswire

    Adient will participate at the Wolfe Research Virtual Autos Conference

    Adient (NYSE: ADNT), a global leader in automotive seating, will present at the Wolfe Research Virtual Autos Conference on Wednesday, Feb. 24, 2021. Adient's executive vice president and chief financial officer, Jeff Stafeil, will be participating in a fireside chat at 8:00 a.m. Eastern time. A live webcast of the fireside chat will be available on the investor section of the Adient website (https://investors.adient.com/).

  • Are Investors Undervaluing Adient (ADNT) Right Now?
    Zacks

    Are Investors Undervaluing Adient (ADNT) Right Now?

    Here at Zacks, our focus is on the proven Zacks Rank system, which emphasizes earnings estimates and estimate revisions to find great stocks. Nevertheless, we are always paying attention to the latest value, growth, and momentum trends to underscore strong picks.

  • Adient (ADNT) Q1 Earnings Beat, Sales Fall Shy of Estimates
    Zacks

    Adient (ADNT) Q1 Earnings Beat, Sales Fall Shy of Estimates

    Adient (ADNT) surpasses fiscal first-quarter 2021 earnings mark on higher-than-anticipated EBITDA across each of the segments.